Schweiter Technologies AG (LON:0QR1)

CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	508	521	693	946	1,568	1,731
Market Cap Growth	-1.40%	-24.77%	-26.75%	-39.69%	-9.38%	26.45%
Enterprise Value	512	538	729	951	1,517	1,679
Last Close Price	359.96	347.79	448.75	609.06	950.47	1026.33
PE Ratio	93.83	44.46	26.92	36.21	22.94	20.20
PS Ratio	0.57	0.59	0.70	0.88	1.58	1.80
PB Ratio	0.82	0.82	1.05	1.40	2.49	2.83
P/TBV Ratio	1.13	1.12	1.43	1.82	3.27	3.79
P/FCF Ratio	10.52	9.11	15.95	-	47.68	17.23
P/OCF Ratio	8.02	6.90	9.49	21.86	23.38	13.25
EV/Sales Ratio	0.56	0.60	0.73	0.89	1.53	1.75
EV/EBITDA Ratio	8.05	10.45	10.23	15.21	13.70	12.44
EV/EBIT Ratio	28.28	28.13	16.10	25.42	17.29	15.08
EV/FCF Ratio	10.61	9.41	16.79	-	46.12	16.72
Debt / Equity Ratio	0.15	0.15	0.16	0.11	0.05	0.05
Debt / EBITDA Ratio	1.48	1.53	1.25	1.00	0.28	0.22
Debt / FCF Ratio	1.93	1.67	2.36	-	1.02	0.32
Asset Turnover	0.93	0.96	1.01	1.08	1.10	1.08
Inventory Turnover	2.80	2.74	2.86	3.16	3.33	3.33
Quick Ratio	1.19	1.26	1.29	1.36	1.73	2.04
Current Ratio	2.17	2.22	2.22	2.44	2.90	3.05
Return on Equity (ROE)	0.76%	1.81%	3.78%	3.81%	11.14%	14.12%
Return on Assets (ROA)	1.14%	1.28%	2.86%	2.34%	6.04%	7.82%
Return on Capital (ROIC)	1.49%	1.65%	3.68%	3.16%	8.49%	10.96%
Return on Capital Employed (ROCE)	2.40%	2.50%	5.80%	4.70%	11.40%	14.70%
Earnings Yield	1.07%	2.25%	3.71%	2.76%	4.36%	4.95%
FCF Yield	9.50%	10.97%	6.27%	-0.22%	2.10%	5.80%
Dividend Yield	3.63%	3.80%	3.12%	2.95%	3.41%	3.23%
Payout Ratio	364.41%	161.65%	103.62%	196.91%	67.89%	55.36%
Buyback Yield / Dilution	0.14%	0.00%	-	-	-	-
Total Shareholder Return	3.77%	3.81%	3.12%	2.95%	3.41%	3.23%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.